These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37269441)

  • 21. Comparison of online reporting systems and their compatibility check with respective adverse drug reaction reporting forms.
    Maharshi V; Nagar P
    Indian J Pharmacol; 2017; 49(5):374-382. PubMed ID: 29515278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study.
    Caldeira D; Rodrigues R; Abreu D; Anes AM; Rosa MM; Ferreira JJ
    Expert Opin Drug Saf; 2018 Apr; 17(4):339-345. PubMed ID: 29463153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.
    Inch J; Watson MC; Anakwe-Umeh S
    Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters.
    Cox AR; Anton C; McDowell SE; Marriott JF; Ferner RE
    Br J Clin Pharmacol; 2010 May; 69(5):529-34. PubMed ID: 20573089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacovigilance Reports Received from Children and Young People, and Development of Information to Aid Future Reporting from this Age Group.
    Bhoombla N; Preston J; Ainsworth J; Bird H; Jadeja M; King C; Hawcutt DB
    Paediatr Drugs; 2020 Jun; 22(3):335-341. PubMed ID: 32253722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record.
    Tillman EM; Suppes SL; Feldman K; Goldman JL
    J Clin Pharmacol; 2021 Feb; 61(2):181-186. PubMed ID: 32776356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
    Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
    Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009.
    Aldea A; García Sánchez-Colomer M; Fernández Quintana E; García Sáiz M
    Eur J Clin Pharmacol; 2012 Sep; 68(9):1329-38. PubMed ID: 22415248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacovigilance of herbal medicines : a UK perspective.
    Barnes J
    Drug Saf; 2003; 26(12):829-51. PubMed ID: 12959628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.
    Tabali M; Ostermann T; Jeschke E; Witt CM; Matthes H
    J Manag Care Pharm; 2012; 18(6):427-38. PubMed ID: 22839683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator.
    Deslandes PN; Bracchi R; Jones K; Haines KE; Carey E; Adams A; Walker J; Thomas A; Routledge PA
    Br J Clin Pharmacol; 2022 Aug; 88(8):3829-3836. PubMed ID: 35322450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria.
    Adisa R; Omitogun TI
    BMC Health Serv Res; 2019 Dec; 19(1):926. PubMed ID: 31796034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.
    Cox AR; Marriott JF; Wilson KA; Ferner RE
    J Clin Pharm Ther; 2004 Feb; 29(1):31-5. PubMed ID: 14748895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective.
    Anderson C; Krska J; Murphy E; Avery A;
    Br J Clin Pharmacol; 2011 Nov; 72(5):806-22. PubMed ID: 21496066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads.
    Castel JM; Figueras A; Pedrós C; Laporte JR; Capellà D
    Drug Saf; 2003; 26(14):1049-55. PubMed ID: 14583065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation.
    Aziz AA; Rogers S; Hassanien O; Shalaby L; Nagy M
    Per Med; 2022 Nov; 19(6):495-507. PubMed ID: 36239598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of adverse drug reactions through the minimum basic data set.
    Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E
    Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.